Performance of Tokyo Guidelines 2018 and Predictors of Mortality in Acute Cholangitis Patients in Indonesia
Keywords:
acute cholangitis, Mortality, Tokyo guidelines 2018Abstract
Background: Acute cholangitis is associated with high mortality, necessitating prompt diagnosis and intervention. The Tokyo Guidelines 2018 (TG18) are a crucial diagnostic tool, but their sensitivity and specificity require evaluation. Moreover, factors influencing acute cholangitis mortality in Indonesia remain unidentified. This study evaluates the diagnostic accuracy of TG18 and identifies mortality predictors in adult patients with acute cholangitis in Indonesia. Methods: A retrospective cohort study was conducted using the medical records of acute cholangitis patients at Cipto Mangunkusumo Hospital from 2019 to 2022. TG18 was compared with endoscopic retrograde cholangiopancreatography (ERCP). Bivariate and multivariate analyses were employed to identify mortality predictors. Results: The study involved 163 individuals (male: 51.5%; mean age: 51.0 ± 12.81 years). The in-hospital mortality rate was 11.6%. TG18 demonstrated a sensitivity and specificity of 84.05% (95% confidence interval (CI):77.51%–89.31%) and 95.65% (95%CI: 78.05%–99.89%), respectively, compared with ERCP. Significant mortality predictors in univariate analysis included TG18 grade III (risk ratio (RR): 13.85; 95%CI: 3.31–57.89; p<0.001), history of malignancy (RR: 4.40; 95%CI: 1.52–12.68; p=0.006), noncompliance with antibiotic guidelines (RR: 3.27; 95%CI: 1.36–7.85; p=0.008), and procalcitonin levels ≥ 2.0 ng/dL (RR: 2.44; 95%CI: 1.056–5.63; p=0.037). Multivariate analysis revealed that significant predictors included TG18 grade III (RR: 10.67; 95%CI: 2.50–45.56; p<0.001), non-compliance with antibiotic guidelines (RR: 2.92; 95%CI: 1.34–6.36; p=0.007), and procalcitonin levels ≥ 2.0 ng/dL (RR: 2.37; 95%CI: 1.18–4.75; p=0.015). Conclusion: TG18 demonstrates favorable sensitivity for diagnosing acute cholangitis. Independent predictors of acute cholangitis mortality include TG18 grade III, noncompliance with antibiotic guidelines, and procalcitonin levels ≥ 2.0 ng/dL.References
Ahmed M. Acute cholangitis - an update. World J Gastrointest Pathophysiol. 2018;9(1):1–7. doi:10.4291/wjgp.v9.i1.1.
An Z, Braseth AL, Sahar N. Acute cholangitis: Causes, diagnosis, and management. Gastroenterol Clin North Am. 2021;50(2):403-14. doi: 10.1016/j.gtc.2021.02.005.
Tringali A. Endoscopic management of acute cholangitis. Gastroenterol Hepatol Open Access. 2016;5(2):208‒213. doi:10.15406/ghoa.2016.05.00133.
Christeven R, Frandy F, Andersen A. Acute cholangitis: An update in management based on severity assessment. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 2018;19(3):170-7. doi:10.24871/1932018170-177.
Yasuda H, Takada T, Kawarada Y, et al. Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14:98–113. doi:10.1007/s00534-006-1162-9.
Allam H, Al Dosouky M, Abdelaziem S, et al. Acute calculous cholangitis in a diverse multi-ethnic population. International Journal of Surgery Open. 2016;2:22–5. doi:10.1016/j.ijso.2016.02.006.
Tan M, Schaffalitzky de Muckadell OB, Laursen SB. Unchanged mortality in patients with acute cholangitis despite an increase in malignant etiologies – a 25-year epidemiological study. Scand J Gastroenterol. 2019;54(3):335–41. doi:10.1080/00365521.2019.1585568.
Touzani S, El Bouazzaoui A, Bouyarmane F, et al. Factors associated with mortality in severe acute cholangitis in a Moroccan intensive care unit: A retrospective analysis of 140 cases. Gastroenterol Res Pract. 2021;1:1-7. doi:10.1155/2021/4583493.
Schneider J, Hapfelmeier A, Thöres S, et al. Mortality risk for acute cholangitis (MAC): a risk prediction model for in-hospital mortality in patients with acute cholangitis. BMC Gastroenterol. 2016;16:15. doi:10.1186/s12876-016-0428-1.
Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepato-Biliary-Pancreat Sci. 2018;25(1):41–54. doi: 10.1002/jhbp 515.
Mohan R, Goh SWL, Tan G, et al. Validation of TG07 and TG13/TG18 criteria for acute cholangitis and predictors of in-hospital mortality in patients over 80 years of age. Clin Exp Hepatol. 2021;7(4):396–405. doi:10.5114/ceh. 2021.110996.
Kiriyama S, Takada T, Hwang TL, et al. Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study. J Hepato-Biliary-Pancreat Sci. 2017;24(6):329–37. doi:10.1002/jhbp.458.
Rumsey S, Winders J, MacCormick AD. Diagnostic accuracy of Charcot’s triad: a systematic review. ANZ J Surg. 2017;87(4):232–8. doi:10.1111/ans.13907.
Hudgi A, Cartelle AL, Ahmed A, et al. Tokyo guidelines (TG18) for acute cholangitis provide improved specificity and accuracy compared to fellow assessment. Cureus. 2022;14(7);1-6. doi:10.7759/cureus 27527.
Yıldız BD, Özden S, Saylam B, et al. Simplified scoring system for prediction of mortality in acute suppurative cholangitis. Kaohsiung J Med Sci. 2018;34(7):415–9. doi:10.1016/j.kjms.2017.12.016.
Ghali MS, Al-Yahri O, Dhaheri MA, et al. Retrospective application and validation of Tokyo 18 guidelines for diagnosis and stratification of acute cholangitis in Qatar. J Emerg Med Trauma Acute Care. 2022;2022(4):1-9. doi:10.5339/jemtac.2022.17.
Raghhupatruni P, Gopalakrishna R, Ankarath V, et al. Profile and outcome of patients with acute cholangitis in a tertiary center in South India. J Dig Endosc. 2021;12(03):127–32. doi:10.1055/s-0041-1739561.
Gyawali B, Ramakrishna K, Dhamoon A. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019;7:1-13. doi:10.1177/2050312119835043.
Elias A, Agbarieh R, Saliba W, et al. SOFA score and short-term mortality in acute decompensated heart failure. Sci Rep. 2020;10(1):20802. doi:10.1038/s41598-020-77967-2.
Umefune G, Kogure H, Hamada T, et al. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study. J Gastroenterol. 2017;52(6):734–45. doi:10.1007/s00535-016-1278-x.
Shinya S, Sasaki T, Yamashita Y, et al. Procalcitonin is a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis. J Hepato-Biliary-Pancreat Sci. 2014;21(10):777–85. doi:10.1002/jhbp.132.
Jain A, Jena A, Gautam V, et al. Role of change in the levels of inflammatory markers post-drainage in predicting outcome in acute cholangitis. Arq Gastroenterol. 2022;59:212–8. doi:10.1590/S0004-2803.202202000-39.
Tagashira Y, Sakamoto N, Isogai T, et al. Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study. Clin Microbiol Infect. 2017;23(10):740–7. doi:10.1016/j.cmi.2017.02.027.
Aboelsoud M, Siddique O, Morales A, et al. Early biliary drainage is associated with favourable outcomes in critically ill patients with acute cholangitis. Przegla̜d Gastroenterol. 2018;13(1):16–21. doi:10.5114/pg.2018.74557.
Nazha B, Moussaly E, Zaarour M, et al. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? World J Gastrointest Surg. 2015;7(12):370–7. doi:10.4240/wjgs.v7.i12.370.
Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12. doi:10.1016/j.ejim.2018.04.014.
Cabral S, Adediran T, Harris A, et al. Factors associated with inappropriate antibiotic use in hospitalized patients. Infection Control & Hospital Epidemiology. 2020;41(S1):s233–s234. doi:10.1017/ice 2020.785.
Du L, Cen M, Zheng X, et al. Timing of performing endoscopic retrograde cholangiopancreatography and inpatient mortality in acute cholangitis: A systematic review and meta-analysis. Clin Transl Gastroenterol. 2020;11(3):e00158. doi:10.14309/ctg. 0000000000000158.
Mulki R, Shah R, Qayed E. Early vs late endoscopic retrograde cholangiopancreatography in patients with acute cholangitis: A nationwide analysis. World J Gastrointest Endosc. 2019;11(1):41–53. doi:10.4253/wjge.v11.i1.41.
Jiménez Castillo RA, Jaquez-Quintana JO, Reyna-Arechiga AI, et al. Risk factors for mortality in patients with acute bacterial cholangitis - Type 2 diabetes is a significant clinical predictor. Rev Espanola Diseases Dig Organ Of Soc Espanola Patol Dig. 2022;114(1):59–61. doi:10.17235/reed. 2021.8251/2021.
Berbudi A, Rahmadika N, Tjahjadi AI, et al. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442–9. doi:10.2174/1573399815666191024085838.
Weissman SDO, Allen MBS, Tangella AV MBBS, et al. S126 comorbid diabetes on hospitalization outcomes in acute pancreatitis. The American Journal of Gastroenterology. 2022;117(10S):p e90. doi:10.14309/01.ajg.0000857144.80477.bb.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Vesri Yoga, Achmad Fauzi, Hasan Maulahela, Hamzah Shatri, Em Yunir, Bradley Jimmy Waleleng, Dadang Makmun, Kaka Renaldi, Cleopas Martin Rumende, Sukamto Sukamto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
